PubMed:21943124 / 976-1112 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/21943124","sourcedb":"PubMed","sourceid":"21943124","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/21943124","text":"Based on the known pathogenesis of Apert syndrome, the chimeric FGFR2 protein is predicted to act in a dominant gain-of-function manner.","tracks":[{"project":"sentences","denotations":[{"id":"TextSentencer_T10","span":{"begin":0,"end":136},"obj":"Sentence"},{"id":"T10","span":{"begin":0,"end":136},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T10","pred":"source","obj":"sentences"},{"subj":"T10","pred":"source","obj":"sentences"}]},{"project":"PubCasesORDO","denotations":[{"id":"AB3","span":{"begin":35,"end":49},"obj":"ORDO:87"}],"namespaces":[{"prefix":"ORDO","uri":"http://www.orpha.net/ORDO/Orphanet_"}],"attributes":[{"subj":"AB3","pred":"source","obj":"PubCasesORDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"sentences","color":"#d293ec","default":true},{"id":"PubCasesORDO","color":"#93ecb7"}]}]}}